Table 2.
Clinical Characteristics of Validation Cohort (N=35)
Clinical Characteristics | N (%) or Median (IQR) |
---|---|
Age, years | 45 (39, 57) |
Race | |
Caucasian | 21 (60) |
Black | 10 (29) |
Other or unknown | 4 (11) |
Breast cancer side | |
Left | 16 (46) |
Right | 14 (40) |
Bilateral | 5 (14) |
Breast cancer nodal status | |
N0 | 15 (43) |
N1 | 13 (37) |
N2 | 5 (14) |
N3 | 2 (6) |
Breast cancer hormonal status | |
ER+ | 18 (51) |
Left-sided Radiotherapy | 16 (46) |
Baseline EF, % | 55 (54, 59) |
Cancer Therapeutics Related Cardiac Dysfunction, % | 18 (51) |